FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211159984> ?p ?o ?g. }

• W4211159984 endingPage "259" @default.
• W4211159984 startingPage "259" @default.
• W4211159984 abstract "Background and Objectives: The impact of direct-acting antiviral (DAA)-based regimens on the recurrence of hepatocellular carcinoma (HCC) after successful curative hepatectomy is controversial. Aims: This study aimed to assess the association between DAAs treatment and recurrence risk in HCC after resection. Materials and Methods: We retrospectively assessed 152 cases of early stage (BCLC stage 0/A) hepatitis C virus (HCV)-related HCC (HCV-HCC) that underwent resection with curative intent between 2001 and 2019 at Kaohsiung Chang Gung Memorial Hospital; 48 cases achieved a sustained virological response (SVR) by DAA, and 104 cases were not treated with any antiviral therapy (non-treatment group). Recurrence-free survival (RFS) following curative resection was analyzed by using the log-rank test and Kaplan-Meier method. A Cox proportional hazards model was used to analyze the factors that impacted RFS and OS. Results: Five patients (10.4%) experienced HCC recurrence after DAA therapy. The cumulative HCC recurrence rate was significantly lower in the DAA group than the non-treatment group (p < 0.001). Multivariate analysis revealed a significant difference in RFS between the non-treatment group and DAA group (p = 0.001; hazard ratio (HR), 4.978; 95% CI, 1.976-12.542); liver cirrhosis (p = 0.005; HR, 2.062; 95% CI, 1.247-3.410), microvascular invasion (p = 0.001; HR, 2.331; 95% CI, 1.408-3.860) and AFP > 15 ng/mL (p = 0.022; HR, 1.799; 95% CI, 1.089-2.970) were also independent factors for HCC recurrence. ALBI stage II/III (p = 0.005; HR, 3.249; 95% CI, 1.418-7.443) and microvascular invasion (p < 0.001; HR, 4.037 95% CI, 2.071-7.869) were independent factors for OS; no significant difference in OS was observed between the DAA and no DAA treatment groups. Conclusions: DAA treatment could reduce the risk of recurrence after curative treatment for early stage HCC." @default.
• W4211159984 created "2022-02-13" @default.
• W4211159984 creator A5010318588 @default.
• W4211159984 creator A5017452913 @default.
• W4211159984 creator A5029049246 @default.
• W4211159984 creator A5036253468 @default.
• W4211159984 creator A5039083508 @default.
• W4211159984 creator A5040924649 @default.
• W4211159984 creator A5049853138 @default.
• W4211159984 creator A5072360796 @default.
• W4211159984 creator A5078327348 @default.
• W4211159984 creator A5085370169 @default.
• W4211159984 date "2022-02-09" @default.
• W4211159984 modified "2023-09-26" @default.
• W4211159984 title "The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma" @default.
• W4211159984 cites W1881390415 @default.
• W4211159984 cites W1915531325 @default.
• W4211159984 cites W1971837077 @default.
• W4211159984 cites W1980154502 @default.
• W4211159984 cites W2000307707 @default.
• W4211159984 cites W2011122771 @default.
• W4211159984 cites W2027545702 @default.
• W4211159984 cites W2068093256 @default.
• W4211159984 cites W2072160870 @default.
• W4211159984 cites W2092646281 @default.
• W4211159984 cites W2101887942 @default.
• W4211159984 cites W2127313936 @default.
• W4211159984 cites W2282504480 @default.
• W4211159984 cites W2291726879 @default.
• W4211159984 cites W2333367339 @default.
• W4211159984 cites W2347052280 @default.
• W4211159984 cites W2467713285 @default.
• W4211159984 cites W2519498039 @default.
• W4211159984 cites W2556868602 @default.
• W4211159984 cites W2569591942 @default.
• W4211159984 cites W2605090968 @default.
• W4211159984 cites W2620035553 @default.
• W4211159984 cites W2744914748 @default.
• W4211159984 cites W2765365186 @default.
• W4211159984 cites W2895913658 @default.
• W4211159984 cites W2898312159 @default.
• W4211159984 cites W2899461943 @default.
• W4211159984 cites W2928271725 @default.
• W4211159984 cites W2992318779 @default.
• W4211159984 cites W3037466317 @default.
• W4211159984 cites W3083926924 @default.
• W4211159984 cites W3087498702 @default.
• W4211159984 cites W3108066810 @default.
• W4211159984 cites W4232620598 @default.
• W4211159984 doi "https://doi.org/10.3390/medicina58020259" @default.
• W4211159984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35208582" @default.
• W4211159984 hasPublicationYear "2022" @default.
• W4211159984 type Work @default.
• W4211159984 citedByCount "2" @default.
• W4211159984 countsByYear W42111599842023 @default.
• W4211159984 crossrefType "journal-article" @default.
• W4211159984 hasAuthorship W4211159984A5010318588 @default.
• W4211159984 hasAuthorship W4211159984A5017452913 @default.
• W4211159984 hasAuthorship W4211159984A5029049246 @default.
• W4211159984 hasAuthorship W4211159984A5036253468 @default.
• W4211159984 hasAuthorship W4211159984A5039083508 @default.
• W4211159984 hasAuthorship W4211159984A5040924649 @default.
• W4211159984 hasAuthorship W4211159984A5049853138 @default.
• W4211159984 hasAuthorship W4211159984A5072360796 @default.
• W4211159984 hasAuthorship W4211159984A5078327348 @default.
• W4211159984 hasAuthorship W4211159984A5085370169 @default.
• W4211159984 hasBestOaLocation W42111599841 @default.
• W4211159984 hasConcept C126322002 @default.
• W4211159984 hasConcept C141071460 @default.
• W4211159984 hasConcept C143998085 @default.
• W4211159984 hasConcept C146357865 @default.
• W4211159984 hasConcept C151730666 @default.
• W4211159984 hasConcept C159110652 @default.
• W4211159984 hasConcept C203014093 @default.
• W4211159984 hasConcept C207103383 @default.
• W4211159984 hasConcept C2522874641 @default.
• W4211159984 hasConcept C2776408679 @default.
• W4211159984 hasConcept C2776909242 @default.
• W4211159984 hasConcept C2777214474 @default.
• W4211159984 hasConcept C2778019345 @default.
• W4211159984 hasConcept C2780593183 @default.
• W4211159984 hasConcept C2993512173 @default.
• W4211159984 hasConcept C3020491458 @default.
• W4211159984 hasConcept C44249647 @default.
• W4211159984 hasConcept C50382708 @default.
• W4211159984 hasConcept C71924100 @default.
• W4211159984 hasConcept C86803240 @default.
• W4211159984 hasConcept C90924648 @default.
• W4211159984 hasConceptScore W4211159984C126322002 @default.
• W4211159984 hasConceptScore W4211159984C141071460 @default.
• W4211159984 hasConceptScore W4211159984C143998085 @default.
• W4211159984 hasConceptScore W4211159984C146357865 @default.
• W4211159984 hasConceptScore W4211159984C151730666 @default.
• W4211159984 hasConceptScore W4211159984C159110652 @default.
• W4211159984 hasConceptScore W4211159984C203014093 @default.
• W4211159984 hasConceptScore W4211159984C207103383 @default.
• W4211159984 hasConceptScore W4211159984C2522874641 @default.
• W4211159984 hasConceptScore W4211159984C2776408679 @default.

• next